CIAM
BIOA

Caitong International Asset Management’s BioAge Labs BIOA Stock Holding History

Caitong International Asset Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.64K Buy
+208
New +$4K ﹤0.01% 1163
2025
Q2 		– Sell
-2,277
Closed -$8.56K – 2576
2025
Q1 		$8.56K Buy
2,277
+1,834
+414% +$8.48K 0.01% 891
2024
Q4 		$2.56K Buy
+443
New +$7.64K ﹤0.01% 1139

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Caitong International Asset Management's BIOA Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in BioAge Labs (BIOA) in Q1 2026: 208 shares worth $3.64K. The stake represents ﹤0.01% of the portfolio and ranks #1163 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in BIOA as recently as Q1 2025.

Caitong International Asset Management first reported a position in BIOA in Q4 2024 and has held it in 3 quarters since. The position peaked at $8.56K in Q1 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Caitong International Asset Management held 208 shares of BioAge Labs worth $3.64K as of Q1 2026.
  • BioAge Labs was a new Caitong International Asset Management position in Q1 2026.
  • BioAge Labs made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1163 holding.
  • Caitong International Asset Management first reported a position in BioAge Labs in Q4 2024 and has held it in 3 quarters since.
  • Caitong International Asset Management's BioAge Labs position peaked at $8.56K in Q1 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.